Canada Pension Plan Investment Board Ligand Pharmaceuticals Inc Transaction History

Canada Pension Plan Investment Board

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$99.52 - $215.83 $466,052 - $1.01 Million	-4,683 Closed	0 $0
Q4 2020 Feb 17, 2021	BUY	$80.55 - $106.05 $377,215 - $496,632	4,683 New	4,683 $466,000
Q3 2020 Nov 12, 2020	SELL	$89.56 - $126.72 $1,432 - $2,027	-16 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$68.28 - $123.65 $282,406 - $511,416	-4,136 Reduced 99.61%	16 $2,000
Q1 2020 May 13, 2020	BUY	$63.37 - $107.88 $68,756 - $117,049	1,085 Added 35.38%	4,152 $302,000
Q4 2019 Feb 14, 2020	BUY	$96.94 - $113.59 $297,314 - $348,380	3,067 New	3,067 $320,000
Q2 2019 Aug 12, 2019	SELL	$107.38 - $129.34 $3.97 Million - $4.79 Million	-37,000 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$105.93 - $142.47 $5.42 Million - $7.29 Million	-51,200 Reduced 58.05%	37,000 $4.65 Million
Q4 2018 Feb 06, 2019	BUY	$128.36 - $272.13 $6.62 Million - $14 Million	51,600 Added 140.98%	88,200 $12 Million
Q3 2018 Nov 09, 2018	BUY	$211.18 - $274.49 $7.73 Million - $10 Million	36,600 New	36,600 $10 Million

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.95B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

Stay updated on Canada Pension Plan Investment Board with notifications on news.